Kenji Omae

2.8k total citations
125 papers, 1.8k citations indexed

About

Kenji Omae is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Kenji Omae has authored 125 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 30 papers in Surgery and 29 papers in Molecular Biology. Recurrent topics in Kenji Omae's work include Renal cell carcinoma treatment (45 papers), Renal and related cancers (25 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Kenji Omae is often cited by papers focused on Renal cell carcinoma treatment (45 papers), Renal and related cancers (25 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Kenji Omae collaborates with scholars based in Japan, United Kingdom and United States. Kenji Omae's co-authors include Tsunenori Kondo, Toshio Takagi, Kazunari Tanabe, Junpei Iizuka, Hirohito Kobayashi, Kazuhiko Yoshida, Hiroki Ishihara, Osamu Taguchi, Tatsuya Chonan and Yasunobu Hashimoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kenji Omae

120 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Omae Japan 23 760 437 330 311 203 125 1.8k
Javier Pintos Canada 24 365 0.5× 270 0.6× 193 0.6× 274 0.9× 425 2.1× 47 1.9k
Wan‐Yu Lin Taiwan 24 322 0.4× 306 0.7× 446 1.4× 324 1.0× 114 0.6× 135 2.0k
Dirk Taeger Germany 24 603 0.8× 241 0.6× 244 0.7× 115 0.4× 376 1.9× 99 1.6k
Michael Hennig Germany 31 695 0.9× 692 1.6× 341 1.0× 385 1.2× 70 0.3× 70 3.1k
H. Marike Boezen Netherlands 26 468 0.6× 177 0.4× 357 1.1× 342 1.1× 266 1.3× 50 2.0k
Min Zhou China 25 410 0.5× 169 0.4× 234 0.7× 867 2.8× 594 2.9× 112 2.7k
Jie Xiao China 27 336 0.4× 150 0.3× 460 1.4× 279 0.9× 474 2.3× 132 2.4k
Sheng Nie China 20 325 0.4× 225 0.5× 492 1.5× 82 0.3× 285 1.4× 85 2.3k
Jinsheng Xu China 15 311 0.4× 302 0.7× 493 1.5× 84 0.3× 98 0.5× 52 2.5k

Countries citing papers authored by Kenji Omae

Since Specialization
Citations

This map shows the geographic impact of Kenji Omae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Omae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Omae more than expected).

Fields of papers citing papers by Kenji Omae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Omae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Omae. The network helps show where Kenji Omae may publish in the future.

Co-authorship network of co-authors of Kenji Omae

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Omae. A scholar is included among the top collaborators of Kenji Omae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Omae. Kenji Omae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishihara, Hiroki, Kenji Omae, Takayuki Nakayama, et al.. (2025). Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 43(10). 598.e1–598.e10. 2 indexed citations
2.
Yoshida, Mikako, Takahiko Mitsui, Noritoshi Sekido, et al.. (2025). Prevalence and risk factors of stress urinary incontinence in a 2023 Japanese community health survey ‐ differences between males and females. BJUI Compass. 6(2). e70004–e70004. 1 indexed citations
3.
Sekido, Noritoshi, Kenji Omae, Nobuhiro Haga, et al.. (2025). Impact of Lower Urinary Tract Symptoms on Daily Life in Individuals With Co‐Existence Overactive and Underactive Bladder, Overactive Bladder, and Underactive Bladder. LUTS Lower Urinary Tract Symptoms. 17(5). e70026–e70026. 1 indexed citations
4.
Sahker, Ethan, Yan Luo, Kenji Omae, et al.. (2025). Estimating the smallest worthwhile difference of recommended psychotherapies for depression: observational study. The British Journal of Psychiatry. 1–8.
7.
8.
Horie, Hiroshi, Satoshi Ogiso, Tomoaki Yoh, et al.. (2023). Albumin-Bilirubin Score at Post-Hepatectomy Hepatocellular Carcinoma Recurrence: Impact on Survival and Association with Post-Hepatectomy Liver Failure. Journal of Gastrointestinal Surgery. 27(11). 2414–2423. 3 indexed citations
9.
Omae, Kenji, Tsunenori Kondo, Shingo Fukuma, et al.. (2023). Effects of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. Journal of Robotic Surgery. 17(5). 2081–2087.
10.
Kimachi, Miho, Kenji Omae, Tsukasa Kamitani, & Shingo Fukuma. (2021). Primary care physicians' perceptions concerning engagement in cancer survivor care. Journal of General and Family Medicine. 23(3). 149–157. 2 indexed citations
11.
Takagi, Toshio, Hironori Fukuda, Hiroki Ishihara, et al.. (2020). Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era. Urologic Oncology Seminars and Original Investigations. 38(5). 515–520. 14 indexed citations
12.
Nishiwaki, Hiroki, et al.. (2019). Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients; a cross-sectional study. BMC Nephrology. 20(1). 121–121. 6 indexed citations
13.
Kanda, Mitsuro, Masahiko Koike, Chie Tanaka, et al.. (2019). Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis. BMC Surgery. 19(1). 143–143. 28 indexed citations
14.
Ishihara, Hiroki, Toshio Takagi, Tsunenori Kondo, et al.. (2018). Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma. Japanese Journal of Clinical Oncology. 48(7). 667–672. 14 indexed citations
15.
Ishihara, Hiroki, Toshio Takagi, Tsunenori Kondo, et al.. (2018). Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. International Journal of Clinical Oncology. 23(3). 559–567. 11 indexed citations
16.
Asakura, Keiko, Makiko Nakano, & Kenji Omae. (2018). Relationship between bidet toilet use and haemorrhoids and urogenital infections: a 3-year follow-up web survey. Epidemiology and Infection. 146(6). 763–770. 9 indexed citations
17.
Omae, Kenji, et al.. (2018). 地域在住高齢者における高度糖化最終産物と聴覚障害の蓄積との関連性:横断的須賀川研究【Powered by NICT】. Journal of the American Medical Directors Association. 19(3). 235–239. 2 indexed citations
18.
Kobayashi, Hirohito, et al.. (2014). Clinical Symptoms Predict Poor Overall Survival in Chronic-dialysis Patients with Renal Cell Carcinoma Associated with End-stage Renal Disease. Japanese Journal of Clinical Oncology. 44(11). 1096–1100. 1 indexed citations
19.
Maruyama, Yūji, et al.. (2009). Effectiveness of wearing protective devices (gas masks and eye protectors) against exposure to formaldehyde during an anatomy lab course.. 85(3). 120–131. 1 indexed citations
20.
Omae, Kenji, et al.. (1994). Effects of Diborane Inhalation on Sperm in Mice.. Sangyo Igaku. 36(1). 28–29.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026